Progression of liver fibrosis among injection drug users with chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

http://www.wikidata.org/entity/Q40339820

about

Progression of Fibrosis during Chronic Hepatitis C Is Associated with Rapid Virus Evolution Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis A genome-wide genetic screen for host factors required for hepatitis C virus propagation Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis.FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B Meta-analyses of FibroTest diagnostic value in chronic liver disease.Hepatitis C for addiction professionals.Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis Clinical chemistry profiles in injection heroin users from Coastal Region, Kenya Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C.Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.Influence of cannabis use on severity of hepatitis C disease Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease.Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART Stability of liver fibrosis among HCV-infected injection drug users HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.Effective use of FibroTest to generate decision trees in hepatitis C.Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.IL28B and the control of hepatitis C virus infection.Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.Molecular serum markers of liver fibrosis.Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-β1: role of TGF-β1 in HCV replication Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods.Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs.Hepatitis in AIDS patients.MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia.

P2860

Q27480339-DDCF374E-DE98-4037-9D98-82274B803BD4 Q27480999-17464706-5E81-4724-BE88-00E324FF1E16 Q27489773-B14E33C1-3793-4EEE-BB49-386A246E8B13 Q30853941-55F15188-3B9C-4B30-9A9A-608E980C2BD3 Q31170758-48D8A426-85F6-4E7F-B90D-5A8F9460A730 Q33302708-D95304B0-5A10-4FA6-9E3A-536C5242324B Q33553099-D965B751-A80D-4394-A3B5-206D9B4C1ADC Q33862153-C321748F-B957-41EC-ABC1-C3B3B333A147 Q33921088-06CD07D8-F11E-4C93-A4B3-498BAAB655F4 Q33936635-6B830B40-CAED-46CF-9AB2-9FD15461BC55 Q34158177-1085A6E3-225E-493F-92A8-AC89E9AAA203 Q34194979-2F84F540-C2BF-45A1-BFF0-6168D8F540DD Q34577683-3757184B-9800-4629-BC3F-012A8ED50197 Q34598615-FFA3CB1D-8DDE-4BE7-93B7-313CBE45DBCD Q34686484-762A6A7F-9077-430A-BDE3-6A80D7D95CF6 Q34775968-CB52C532-B205-4D3A-B268-789FDC3B89BD Q34974095-6A4EF2AF-B2B4-4C5E-BB4A-F7D8A3C4861B Q35000910-A42A8412-862A-4258-87E4-A5A74AB70D70 Q35167113-CF7950DE-F928-4801-84DB-F5CAAC18B08C Q35250832-657ED2A6-F070-4277-8969-25E1D90B0EC3 Q35507424-5B912545-B8AA-45CA-8E1F-6890D5E4AA03 Q36079851-9932E19C-4989-4C8E-9ACC-E26458501D30 Q36105884-81A8CBB0-E8AE-46C7-92C9-C006AC2C2D15 Q36975862-2A51C58A-F6B5-4D83-ACCD-6F01F49250CD Q37003644-74DD946F-BB10-4D52-9015-FE56A34E1D75 Q37214588-3576EB3C-237D-478A-96AC-86D16B49B35A Q37270537-3DB15F35-7565-4A53-B281-B05539F2DFA7 Q37275793-65AE6A2F-78F4-4B8E-A8C0-D9676DFC28B0 Q37400658-84E9A516-B378-475B-8519-AD5D99BB33F6 Q37800518-05E95412-0BE3-4597-9657-CD8288C05B57 Q37841383-ECDA68D7-0264-4F2C-B936-D3AE4D5A2342 Q38032835-F9A33DB1-B160-4E44-962D-9B91CBF457BA Q39597392-53CE74E4-DA66-4571-A6FB-CA440785B9C1 Q40280432-D59466A0-8168-4F7E-ADF4-5F3D85AD538B Q43210156-A23B8E27-DE90-4D01-97B3-D06B6E578640 Q47554747-8B8561D3-D32B-451F-98E5-2BABF4420C47 Q48191650-D576A1EC-32B4-4597-AB42-792DE0E35DCE Q53697565-4C10B05E-79AF-492E-BC4A-EC16A27E5C22

P2860

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

http://www.wikidata.org/entity/Q40339820

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

@en

type

label

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

@en

prefLabel

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

@en

P1433

Q40339820-30B1112D-EAFE-469C-95C0-FCBA29D55779

P1476

Q40339820-4D9E9F5A-BEED-4D57-88D4-CCED2EAB5C97

P2093

Q40339820-05365A94-4A66-4DCD-912A-F191947B85C1

Q40339820-0908E135-00AD-4A8F-B22C-A86A7BEA1579

Q40339820-1E32B69C-9DDC-4E14-B7CC-E8604DCD8D90

Q40339820-44FC4485-EC47-4B73-87C5-11514614459F

Q40339820-5EE43D5A-E78F-4EA8-B5B3-8871B910C80A

Q40339820-A1E51BF5-59F2-4D78-83D7-B27DBAEF8B40

Q40339820-A570E32F-A7E5-4CDF-9FD7-5B31099DE98E

Q40339820-A6D42636-1375-4367-880F-472056C25E39

Q40339820-E1A8F2A7-78C8-45F5-8D99-2BA0C296F6DF

Q40339820-FF36377B-0348-4321-B6DA-C9DBD8972F7F

P2860

Q40339820-A909D385-8060-41E5-A78E-924709163461

P304

Q40339820-FDC895CD-4E58-4961-8324-957004200B11

P31

Q40339820-D8C44700-D756-48F2-8137-DE5EE94227A0

P356

Q40339820-5839BDB2-AFAC-4C0C-A1BF-9E5EC77C78AA

P407

Q40339820-3B844100-46BE-463B-A7B7-719A8FD367B9

P433

Q40339820-6080B3BB-2113-408C-8E00-D109662BD132

P478

Q40339820-3FC0E05B-F96F-4950-8148-E0729BCFBA3B

P50

Q40339820-A163C8F5-5642-4C05-8233-FFC4D9E01482

P577

Q40339820-9DCE686C-CFD7-46F7-ACF2-CD9A9AD35150

P698

Q40339820-154C02A1-1C88-4470-BD80-AE9CBD2B96F9

P356

P1433

P1476

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

@en

P2093

Charles Spoler

http://www.w3.org/2001/XMLSchema#string

David L Thomas

http://www.w3.org/2001/XMLSchema#string

Gregory D Kirk

http://www.w3.org/2001/XMLSchema#string

Hawazin Faruki

http://www.w3.org/2001/XMLSchema#string

Jacquie Astemborski

http://www.w3.org/2001/XMLSchema#string

Kenrad Nelson

http://www.w3.org/2001/XMLSchema#string

Lucy E Wilson

http://www.w3.org/2001/XMLSchema#string

Michael Torbenson

http://www.w3.org/2001/XMLSchema#string

Rudra Rai

http://www.w3.org/2001/XMLSchema#string

Shruti Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Association of hepatitis C virus infection with false-positive tests for syphilis.

P304

788-795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21091

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16557548

http://www.w3.org/2001/XMLSchema#string